Cite

    Yanli Wang et al.. “A randomized, double-blind, single-dose, two-way, parallel phase I clinical study comparing the pharmacokinetics and safety of adalimumab injecta and Humira® in healthy Chinese male volunteers.” Expert opinion on biological therapy, vol. 22, 2022, pp. 225–234. http://access.bl.uk/ark:/81055/vdc_100152273226.0x00001d